Aerovate Therapeutics Stock Price on August 14, 2024
| AVTE Stock | USD 2.53 0.03 1.17% |
If you're considering investing in Aerovate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aerovate Therapeutics stands at 2.53, as last reported on the 23rd of December, with the highest price reaching 2.64 and the lowest price hitting 2.45 during the day. Aerovate Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Aerovate Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aerovate Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Aerovate Therapeutics' Downside Deviation of 2.41, mean deviation of 2.34, and Risk Adjusted Performance of 0.1044 to double-check if our risk estimates are consistent with your expectations.
At present, Aerovate Therapeutics' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 53.1 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 98.2 M. . At present, Aerovate Therapeutics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 5.72, whereas Price Earnings To Growth Ratio is forecasted to decline to (0.23). Aerovate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Aerovate |
Sharpe Ratio = 0.1291
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AVTE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.49 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.45 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Aerovate Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aerovate Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.9159 | Book Value 2.788 | Enterprise Value -14.5 M | Enterprise Value Ebitda (9.33) | Shares Float 11.8 M |
Related Headline
Karyopharm Therapeutics Headline on 14th of August 2024
Disposition of 3608 shares by Paulson Richard A. of Karyopha... by Paulson Richard A.
Filed transaction by Karyopharm Therapeutics Director, Officer President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Aerovate Therapeutics Valuation on August 14, 2024
It is possible to determine the worth of Aerovate Therapeutics on a given historical date. On August 14, 2024 Aerovate was worth 1.75 at the beginning of the trading date compared to the closed value of 1.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aerovate Therapeutics stock. Still, in general, we apply an absolute valuation method to find Aerovate Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aerovate Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aerovate Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.71 | 1.77 | 1.70 | 1.75 | 204,643 | |
08/14/2024 | 1.75 | 1.76 | 1.68 | 1.72 | 96,229 |
| 1.77 | 1.86 | 1.73 | 1.79 | 142,802 |
| Backtest Aerovate Therapeutics | | | Aerovate Therapeutics History | | | Aerovate Therapeutics Valuation | Previous | Next |
Aerovate Therapeutics Trading Date Momentum on August 14, 2024
| On August 15 2024 Aerovate Therapeutics was traded for 1.79 at the closing time. The top price for the day was 1.86 and the lowest listed price was 1.73 . The trading volume for the day was 142.8 K. The trading history from August 15, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 4.07% . The overall trading delta against the current closing price is 8.72% . |
Aerovate Therapeutics Fundamentals Correlations and Trends
By evaluating Aerovate Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aerovate Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aerovate financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aerovate Therapeutics Stock history
Aerovate Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aerovate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aerovate Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aerovate Therapeutics stock prices may prove useful in developing a viable investing in Aerovate Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.3 M | 27.3 M | |
| Net Loss | -20.7 M | -19.7 M |
Aerovate Therapeutics Quarterly Net Working Capital |
|
Aerovate Therapeutics Stock Technical Analysis
Aerovate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aerovate Therapeutics Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Aerovate Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aerovate Therapeutics December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Aerovate Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aerovate Therapeutics shares will generate the highest return on investment. By undertsting and applying Aerovate Therapeutics stock market strength indicators, traders can identify Aerovate Therapeutics entry and exit signals to maximize returns
Aerovate Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aerovate Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aerovate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aerovate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1044 | |||
| Jensen Alpha | 0.4065 | |||
| Total Risk Alpha | 0.3222 | |||
| Sortino Ratio | 0.1653 | |||
| Treynor Ratio | 0.6356 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Aerovate Stock analysis
When running Aerovate Therapeutics' price analysis, check to measure Aerovate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aerovate Therapeutics is operating at the current time. Most of Aerovate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aerovate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aerovate Therapeutics' price. Additionally, you may evaluate how the addition of Aerovate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |